Argent Biopharma Limited has released a press release.
Major EU Pharma Supply Agreement Signed with Lenis
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Appendix 4E and Audited 2017 Financial Report
- RMIT and MGC Pharmaceuticals Sign Strategic Agreement
- Botanical Division Update - Europe and Australia
- First European Distribution Deal Signed for API Products
- EU Medical Cannabis License Granted with Strategic Agreement
Later from Argent Biopharma
- MXC Botanic Division Operational Update
- $40 Million White-Label CBD Cosmetics Agreement Executed
- First $8m Binding Cosmetics Sales Agreement Signed
- MXC Enters Multi $M Australian Pharma Market
- First Varm Cosmo Binding Purchase Order Received
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma